chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient is full vaccinated and boosted.  COVID + on 2/3/2022 on admission to the hospital. Presented to the ED with complaint of shortness of breath/chest pain.She was also having productive cough. Pt was hypoxic requiring oxygen. Workup initially showed acute kidney injury with creatinine of 1.99 above from baseline with normal BNP level; however, positive repeat echo and a chest x-ray concerning for vascular congestion. DX: acute renal failure, COVID pneumonia, CHF, HTN, transient ischemic attack, Treatment:  antibiotics, steriod, nebulizer, metoprolol.  Pt discharged home.
The evening of my booster shot I began getting body aches and chills. That first night through the following night (a full 36 hours) I was feverish, in and out of consciousness, nauseated, in immense pain, had body aches and chills and sweat massive amounts, soaking out bed numerous times. As of around noon the 2nd day after (roughly 48hrs after injection) I feel mostly better, just lethargic and weak from such a horrible experience.
This spontaneous report as received from internet referred to unspecified number of female patients of unknown age. On an unknown date the patients were vaccinated with GARDASIL (Lot#, dose/frequency, route and duration were unspecified). Then on an unknown date the patients experienced paralysis (more reports of paralysis in girls who have gotten the poorly tested HPV vaccine). At the time of reporting the outcome of relationship were unknown. Upon internal review, paralysis was considered as other medical significant event. This is one of several reports that received from the same source. Additional information has been requested.
Extreme shoulder pain with decreased ROM of the right shoulder. Treatment included NSAID and physical therapy.
This is a spontaneous report from a contactable consumer (patient) and another contactable consumer (patient's wife). A 56-year-old male patient received the first dose of bnt162b2 (COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 08Apr2021 at 08:30 (Batch/Lot Number: ER8729) as single dose for covid-19 immunisation. Medical history included ongoing heart patient, and penicillin allergy from an unknown date. Ongoing concomitant medications included carvedilol, lisinopril, clopidogrel bisulfate (PLAVIX), and acetylsalicylic acid (ASPIRIN (E.C.)). The patient experienced wiped out, tired and slept on 08Apr2021, left arm tenderness on 08Apr2021, lower back pain, pain in his abdomen, pain in his shoulders, vomiting, lightheaded and dizzy, really super flushed and turn almost a reddish purple on 10Apr2021, kidney pain on 11Apr2021 at 04:00, parotid cheek gland pain and yellow pus coming out of it on 13Apr2021. The events required physician office visit. Seriousness was not reported for events. Clinical course: The reporter stated her husband got his first dose of the vaccine on 8Apr2021. States on the 8Apr2021 and 9Apr2021, he was wiped out, which was normal. He developed kidney pain, lower back pain, pain in his abdomen and pain in his shoulders. He also developed an area in his cheek gland inside of his mouth that had disgusting yellow stuff coming out of it. He was at a doctor's appointment at Hospital being seen by a specialist for it now because it was so painful. The patient was tired and slept and had left arm tenderness from 8Apr2021-9Apr2021. The patient had vomiting from 10APR-13APR2021. He would get really super flushed and turn almost a reddish purple and lay on the ground to make it go away and also complaining of pain. The patient would start feeling lightheaded and dizzy, and had to run to the bathroom and throw up and then he would be okay for an hour or two and then it would come again. The pain was off and on, certain times he was doubled over in pain and it started again. It was the gland inside of his cheek, up by his upper gum line on the inside of his cheek gland, and it had yellow pus coming out of it. He had a stone removed from that cheek gland 3 years ago but he has had zero problems since then. States it was the parotid gland that came out of the salivary gland where it came in to the mouth. States that was where it has pus on the inside of his cheek. The outcome of events wiped out, tired and slept, left arm tenderness was resolved on 09Apr2021, outcome of events vomiting, lightheaded and dizzy, really super flushed and turn almost a reddish purple was resolved on 13Apr2021, outcome of other events was not resolved. No follow-up attempts are needed. No further information is expected.
Patient developed chest tightness, pressure, palpitations and had +EKG changes and troponin elevation. He was admitted to hospital 5/18/21-5/20/21 for studies and treatment, final diagnosis was pericarditis.
Mucousy, blood tinged stool - 3 times.  Has not happened since then.
This spontaneous report was received from a registered nurse and refers to multiple unspecified patients of unknown age and gender. There was no information about the patients' concurrent conditions concomitant therapies or medical history provided. On unknown dates, reported as multiple unspecified dates, the patients were vaccinated with improperly stored doses of VAQTA (strength, dose, anatomical location, lot# and expiration date were not reported). Administered doses of VAQTA experienced temperature excursion of 0.4 degrees Celsius for 89 hours and 5 minutes, on an unknown date. Temperature was logged with a data logger, and there were no previous temperature excursions. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
ED visit - Needs psychiatric admission for suicide attempt, COVID positive. Admitted to the hospital 2 days later from the ED. She was medically cleared for that ingestion and initially was to be admitted to medicine due to positive COVID-19, but was found to be no longer symptomatic and outside of the timeframe requiring quarantine, so she is admitted to psychiatry. Treated in behavioral health inpatient for 35 days and then placed at an outside facility.
This case was reported by a pharmacist via call center representative and described the occurrence of cough in a 54-year-old female patient who received SHINGRIX (batch number A4D72, expiry date 23rd May 2021) for prophylaxis. On 8th February 2019, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. In February 2019, less than a day after receiving SHINGRIX, the patient experienced cough. On an unknown date, the outcome of the cough was not recovered/not resolved.  It was unknown if the reporter considered the cough to be related to SHINGRIX. Additional details were provided as follows: The Pharmacist stated one of the patient's was administered second dose of the SHINGRIX vaccine. The night of vaccination patient started experiencing a cough that did not go away. No further details were provided.
A report has been received from a Health Professional via medical representative concerning, a patient of an unknown age and unknown gender. The patient's medical history and concurrent diseases were not provided. The patient concomitant medications were not provided. The patient has received nasal FLUMIST QUADRIVALENT started during Oct-2013. It was reported that patient received FLUMIST in October this year and contracted the flu over thanksgiving (Preferred Term: Influenza). Action taken on suspect drug was unknown. The outcome of the event was unknown. The reporter assessed the event of patient received FLUMIST in/ RN reported to me that patient received FLUMIST in October this year and contracted the flu over thanksgiving/ flu to be non-serious.
approximately 8hrs after vaccination pat had problems swallowing (like a piece of meat in the throat). lasting about an hour. it then got better an hour. it then got better approx. 3 am patient woke up to use restroom & fingers were very stiff (felt icy cold, then wooden - not bending til warmed up). were not swollen. lasted about 20 minutes also had a (low grade fever) 100.8. patient sent portal message to prescribed in morning..no response as of yet.
Beginning around 10:00pm the day of the vaccination, which occurred at 2:00pm, I began to experience chills and went to bed. I woke up several times during the night and felt feverish. I got up once and felt dizzy and had some body aches. At around 7:00 am the following day I took my temperature and it was 99.4 F.  I took acetaminophen at 8:00 am. I went back to bed and was still feverish and sweating. I woke up at 10:15 am and felt much better. My fever was gone and I had no more chills or body aches. After that time no other adverse reactions occurred.
Initially just pain at injection site, then became more intense. Whole upper arm hurt, could not lay on it or touch it. Pain mostly in tricept area. A blotchy, flat rash developed from injection site to elbow on top of arm. Pain, discomfort for a week, rash left a little sooner. Felt tired first 24 hours.
Patient was more lethargic after Hepatitis B vaccine given; trouble latching on to feed, sleeping more, found limp and cyanotic by parents. Unable to arouse but had weak heart rate at 60. Patient intubated and then on vent. Almost immediately extubated but unable to maintain respirations on his own. Increasing respiratory problems over next few days. Had to remain on ventilator. Patient with pooling of secretions. Patient became hypertolic. Hospital records received on 1/22/04 states acute life threatening event, metabolic acidosis , and encephalopathy. The hospital discharge summary received on 2/19/04 states GERD and chronic resp. failure.
Details are unclear but he had a seizure within 2-3 days of having the immunization and also had increased temper tantrums within 1-2 week period.
t102, carried a sl fever around 99 for 4 days, puffy eyes, difficulty breathing, stuffingness, cough;
ONE FOREARM DEVELOPED AN ITCHING RASH ABOUT 5 INCHES WIDE.  BENADRYL 50MG PO GIVEN WITH GOOD RESULTS.
Chills, disorientation, muscle aches in backs of calves, tingling in front of legs, below the knees, feet numb....swelling in arm at vaccination site, as well as under arm in armpit area.
This spontaneous report as received from a registered nurse refers to a 29 year old (approximately) female patient with asthma and drug allergy to NUBAIN. The patient was administered a 3 doses series of RECOMBIVAX HB on an unspecified date as a child (dose, route, and lot number were not reported). Concomitant therapies included SINGULAIR, ADVAIR, and albuterol. The nurse was reported that the patient was then administered does of RECOMBIVAX HB on 01-APR-1993, 17-MAY-1993, 02-NOV-1993, 15-SEP-2010, 09-DEC-2010 and 11-APR-2011 (dose, route and lot number were not reported. The nurse was also reported that a hospital employee had failed to seroconvert after receiving nine doses of RECOMBIVAX HB. It was reported that the Hepatitis B antibody test was negative. The patient received unspecified treatment for the adverse event. The patient's present status was reported as other negative antibody titers. The patient sought medical attention by office visit. At the time of the report, the patient's outcome for the adverse events was unknown. The relatedness for the adverse events was unknown for RECOMBIVAX HB. Additional information has been requested.
I have been experiencing dizziness/vertigo and mild nausea since the day I received the vaccine. It has not gotten better or worse. Just through out the day it comes and goes.
pt recvd vax 13SEP95;29SEP95 pt presented w/maculo papular rash on trunk;DPH prescribed;pt seen 3OCT95 w/bilat swollen parotid area;
pt recv flu vax 29OCT96 & exp tingling sensation & back pain NOV 12, 14, & 15; severe back pain & numbness in face & lower leg;16 & 17 & 18NOV complete facial & lt leg paralysis;(no prior illness);dx GBS
loss of appetite; nauseous; This spontaneous case was reported by a patient and describes the occurrence of DECREASED APPETITE (loss of appetite) and NAUSEA (nauseous) in a 77-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 015H22A) for COVID-19 immunisation.     Patient had no allergies.  Previously administered products included for Drug use for unknown indication: flu vaccine (past month). Past adverse reactions to the above products included No adverse event with flu vaccine. Concurrent medical conditions included Hypertension and Type 1 diabetes mellitus. Concomitant products included LOSARTAN for Hypertension, INSULIN for Type 1 diabetes mellitus.   On 09-Nov-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 09-Nov-2022, the patient experienced DECREASED APPETITE (loss of appetite) and NAUSEA (nauseous). At the time of the report, DECREASED APPETITE (loss of appetite) and NAUSEA (nauseous) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Nov-2022, Blood glucose: high.   Concomitant medications also included insulin pump. On 01 Feb 2021 patient received first dose of Moderna vaccine with lot number 030L20A. On 01 Mar 2021 patient received second dose of Moderna vaccine with lot number 001A21A. On 27 Oct 2021 patient received first booster dose of Moderna vaccine with lot number 025D21A. It was reported that patient had the second booster dose of the Moderna vaccine and was reporting that she was nauseous, has loss of appetite and high blood sugars. Adverse event did not cause patient to seek medical care  Patient did not experienced a similar event in the past. The symptoms were ongoing. No treatment medications were provided.   This case was linked to MOD-2022-670554 (Patient Link).
p/vax pt was crying & pulling @ hair;crying stopped & noticed mouth was rigid;had to pry mouth open & pull tongue away from airway for pt to breath;eyes appeared to roll back;
After my second vaccine on 1/12 at approximately 0730am I developed fever and chills around 1100pm that same day.  I had these symptoms through 0800am on 1/13.  I was recovered from these symptoms on 1/14.  However, by the evening of 1/15 I developed some sinus-related symptoms like sneezing and runny nose. On 1/16 I could not taste or smell anything. I got a PCR COVID test on 1/17 and have not developed any additional symptoms. My sinus related symptoms resolved after 1/17. As of today, 1/22, my PCR results have come back positive.
I never had High BP before but on March 28, 2021   I was experiencing  chest pain, thinking I was having a heart attack.   While in the ER,  my BP was 220 / 90.   Since then my BP is all over the place.    Currently I am not on BP meds.   I overheard someone talking in my cardiologist's office that their BP is high since the Covid Vaccine.   Got me to think,  could it have caused my numbers to be elevated.  I was always 110 / 70 - 120 / 80.
Upper left arm very sore; could not sleep on left side.  1/18/14 - (8:30 AM) body aching; muscle weakness. Symptoms progressively got worse.  By noon time extreme nausea, chills, shivering; fever began and body pain intensifying.  Fever up to 100.5 @ 4:30 pm. Migraine began. Did not medicate due to extreme nausea. Took Phenergan & 500 mg Aspirin.  By 10:00 PM body pain worsening and nausea intensifying.  Sun 1 AM 1/19/14 (1) phenergan & 500 mg more aspirin.  Fever still 100.5.  Fever broke during night with severe sweating. 1:10 PM 500 mg Aspirin & (1) Phenergan; 3:30 pm fever back up to 100.4; took (2) Pepto-Bismol caplets. 7:15 pm Body pain excruciating; 600 mg. Ibuprofen. 8:30 pm severe vertigo/dizziness occurred. Unable to move; broke out in cold, clammy sweat; duration - 5 mins. Mon 1:50 am 400 mg Ibuprofen and (1) Phenergan. Fever broke again during night. 10:55 AM Mon 1/20/14 400 mg. Ibuprofen. Severe muscle pain subsided.
A report was received from a health care professional on 10/29/03 concerned a 7 year old vaccinee of unknown sex who received a sub-optimal dose of Fluvirin on 10/25/03. On 10/25/03, the vaccinee received a 0.25ml Fluvirin instead of 0.5ml. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
itching left arm right arm neck.  Pink on next  ee premedicated with Benadryl 1 pm.  gave Benadryl 25 mg at 4:23 pm
Very Sore upper left arm with deep bruises covering significant part of upper left arm below injection site.
This case was reported by a pharmacist and described the occurrence of arm pain at injection site in a 42-year-old male subject who was vaccinated with FLULAVAL trivalent 2013-2014. On 2 October 2013 the subject received a dose of FLULAVAL 2013-2014 season (unknown, unknown deltoid). At an unspecified time after vaccination with FLULAVAL 2013-2014 season, the subject experienced arm pain at injection site described as local reaction of "arm pain, arm soreness and stinging at injection site". At the time of reporting the events were unresolved. The pharmacist reported another case, please see A1050674A.
Lower-than-authorized dose administered. 6-11 year dose given instead of 12+ dose.
Dizziness when turning in bed, getting up from bed or standing from a sitting position.  Dizziness will also occur when still for no apparent reason. Periods of vertigo.  Head feels heavy and I?m feeling pressure in my ears.  Will sometimes need to steady myself by holding on to chairs, walls, counters etc when walking for fear of losing my balance.  Sometimes the dizziness is accompanied by a headache.  Increased joint pain in my knees but that may or may not be vaccine related.
This spontaneous report as received from a physician refers to an unspecified number of patients of unknown age and gender. No pertinent medical history and drug reactions/allergies were reported. On unspecified dates the unspecified number of patients were vaccinated with improperly stored doses of M-M-R II (lot # L026553 and expiry date 16-JUL-2017) (dosing regimen and route of administration were not reported). No concomitant medications were reported. No adverse effects were reported. No product quality complaint (PQC) was flied. This is one of several reports received from the same reporter. Additional information has been requested.
Injection site redness, swelling, warm to touch, 55mm x 40mm induration and erythema. Also ache and chilled. Prescribed a Medrol dose pack.
PATIENT HAD KINRIX ON 06-23-2009. DEVELOPED RED RAISED SWELLING AT INJECTION SITE ON 06-24-2009. SEEN BY DR. ON 06-25-2009. ALSO AREA WAS WARM BUT NOT TENDER. SIZE OF REDNESS ABOUT 15CM DIAMETER. NO FEVER.
recieved shot on 1/28/21 at 10:10 am , reaction started 1/29/21 in the morning area was red and warm it has progressivly gotten  better over the last couple days she has taken motrin and benadryl. The area was slightly itchy. She has alternated with ice and heat.
Body pain; Exhausted; Joint pain; Nausea; Diarrhea; Vomited; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), PAIN (Body pain), VACCINATION SITE PAIN (Vaccination site pain), VOMITING (Vomited) and FATIGUE (Exhausted) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). On 11-Jan-2021, the patient experienced DIARRHOEA (Diarrhea), VOMITING (Vomited) and NAUSEA (Nausea). On 12-Jan-2021, the patient experienced PAIN (Body pain), FATIGUE (Exhausted) and ARTHRALGIA (Joint pain). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) for Vomiting, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Pain in extremity, at an unspecified dose and frequency. On 08-Jan-2021, VACCINATION SITE PAIN (Vaccination site pain) had resolved. On 12-Jan-2021, DIARRHOEA (Diarrhea), VOMITING (Vomited) and NAUSEA (Nausea) had resolved. At the time of the report, PAIN (Body pain), FATIGUE (Exhausted) and ARTHRALGIA (Joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jan-2021: No specific information was updated.; Sender's Comments: Based on current available information and the temporal association between product and the start date of the events a causal relationship cannot be excluded.
Patient had initial dose with Moderna on 18 MAR. Patient received 2nd dose today, with Pfizer.
Right hand numbness; Right hand tingling; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 09:45 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included glipizide (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication. On 02Apr2021 at 03:00, the patient experienced right hand numbness and tingling. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events right hand numbness and tingling were not recovered.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This case was reported by a consumer and described the occurrence of autism like symptoms in a female, now 3 years of age, who received hepatitis B vaccine recombinant as a neonate. The reporter is the mother of the patient. A physician or other health care professional has not verified this report. On 10/15/01, the patient received the first dose of Engerix B (lot number not specified). At an unspecified period of time following the administration of Engerix B, the patient's physician informed the mother that her daughter had begun "...exhibiting signs of possible autism." The event was ongoing at the time of initial reporting. Comment: Autism like symptoms was assessed as medically serious (OMIC). Reporter refused contact information no new information.
Subconjunctival hemorrhage in left eye next morning. Small in diameter.  No pain.  Also left shoulder pain that lasted 30 hours
Systemic: intermittent ringing in the ear 6 hours after the vaccine given-Mild
pt recvd vax in 1985 & approx 12 hrs following vax pt was unable to walk;
teeth hurt for three days after, day after shot was administered, was short of breath, ran a fever of 101.2, head was tingling, had body aches from my shoulders to me feet, shot was given in left arm, but right arm also hurt, stomach was tender. no more symptoms after day 3 except shortness of breath still, day 5.